Toggle navigation
Home
Medical
Blood Biomarker May Predict Alzheimer's Disease Progression
21-1-2021
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
1091
Changes in plasma levels of p-tau181 are associated with progressive cognitive decline and reduction in gray matter volume in patients with amyloid beta. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
People With This Blood Type May Have Higher Risk Of Early...
Blood Test Shows Promise for Quick Diagnosis of ALS
Many Young Kids With COVID Show No Symptoms of the Disease
Excess weight, not high blood sugar, associated with...
Disease spillover risk poorly communicated,...
Study identifies a promising target for polycystic kidney...
Nursing Matters – how to support patients living with...
Hearts, Minds and Mouths: Defeating Dental Disease the...
Day-of-injury blood tests predict which TBI patients are...
Increased concentrations of GPNMB in blood samples could...